All In MedTech

FDA Clearance Tracker · P160055-S024

Light Adjustable Lens (LAL), Light Delivery Device (LDD) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 31, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 31, 2023

Approved

Time to decision

182 days

Received Sep 30, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P160055-S024
Device name
Light Adjustable Lens (LAL), Light Delivery Device (LDD) System
Applicant
Rxsight, Inc.
Applicant location
Aliso Viejo, CA
Received
Sep 30, 2022
Decided
Mar 31, 2023
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160055

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code PZK

FDA's approval statement

As written in FDA's record.

Approval for a light adjustable lens (LAL) model LAL+ as a level A modification of the optical design of the original LAL.

Source documents

Other decisions for Rxsight, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

4 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.